医学
胃食管交界处
无容量
佐剂
食管癌
胃肠病学
肿瘤科
放化疗
食管切除术
癌症
内科学
腺癌
免疫疗法
作者
Ronan J. Kelly,Jaffer A. Ajani,Jarosław Kużdżał,Thomas Zander,Eric Van Cutsem,Guillaume Piessen,Guillermo Méndez,Josephine Feliciano,Satoru Motoyama,Astrid Lièvre,Hope E. Uronis,Elena Elimova,Cecile Grootscholten,Karen Geboes,Syed Zafar,Stephanie Snow,Andrew H. Ko,Kynan Feeney,Michael Schenker,Piotr Kocoń
标识
DOI：10.1056/nejmoa2032125
摘要
Among patients with resected esophageal or gastroesophageal junction cancer who had received neoadjuvant chemoradiotherapy, disease-free survival was significantly longer among those who received nivolumab adjuvant therapy than among those who received placebo. (Funded by Bristol Myers Squibb and Ono Pharmaceutical; CheckMate 577 ClinicalTrials.gov number, NCT02743494.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
cdercder
Kao
Samuel
yjh123
Copyright
arniu2008
行走的荷尔蒙
OK
Nexus
sagitar
研友_ZbM2qn
悦耳白山
无极微光
学术文献互助
GG
科研狗
liuzhuohao
蓝天
Nole
GingerF
皖公网安备34019202002308
